Kezar Life Sciences

-$0.03 (-0.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD.

CEO
John Fowler
Employees
47
Headquarters
South San Francisco, California
Founded
2015

KZR Key Statistics

Market Cap
260.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
126.52K
High Today
$5.33
Low Today
$4.95
Open Price
$5.13
Volume
97.80K
52 Week High
$7.40
52 Week Low
$4.24

KZR News

Simply Wall StJul 26

Could The Kezar Life Sciences, Inc. Ownership Structure Tell Us Something Useful?

If you want to know who really controls Kezar Life Sciences, Inc. (NASDAQ:KZR), then you'll have to look at the makeup of its share registry. Institutions will

KZR Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure